In summation, the GH-IGF axis may be an important pathway for further investigation in human CKD and in particular stage 4/5 patients, experiencing uremia, inflammation and malnutrition-both as a potential means of assessment of nutritional status/anabolic activity and of treatment. Here, IGF1 is linked to uremia.